Delivery Order SPE2DB22D3401-SPE2DB25FT5YL
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,535.87, is for the delivery of 4,563,689,418 units of the drug Dicyclomine 20 mg tablet. The contract is a Firm Fixed Price Delivery Order with a completion date of February 20, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Dicyclomine 20 mg, a medication commonly used to treat irritable bowel syndrome and related gastrointestinal conditions. This competitively awarded, non-set-aside contract has a ceiling value of $2,388.55 and was finalized on July 30, 2025, with an ultimate completion date of July 31, 2025. The award utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,171.09, is for the delivery of 4,567,154,318 units of the drug dicyclomine 20 mg tablet. The contract has an ultimate completion date of February 5, 2025 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $12,433.95 to AmerisourceBergen Drug Corp under a firm fixed price contract type. The award was issued on August 15, 2025, with an ultimate completion date of the same day, indicating this is a time-sensitive pharmaceutical delivery. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive procurement without set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,497.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of MS Continuous Release Tablets 30mg, with an ultimate completion date of July 31, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that serves...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $50,750.68 by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 28, 2025, and carries no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $16,222.44 to AmerisourceBergen Drug Corp under a firm fixed-price contract with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded delivery order represents a discrete task order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,655.44 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain division. The award, issued on August 20, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside contract. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $122,742.87 to AmerisourceBergen Drug Corp on August 23, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a competitive award to the pharmaceutical distributor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $117,365.33 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 16, 2025, with an ultimate completion date of August 18, 2025. The contract represents a child award under AmerisourceBergen's broader relationship with the federal government's military healthcare...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5YLDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,130.53 for 1,000 tablets of Dicyclomine 20 mg, a medication commonly prescribed for gastrointestinal conditions. The contract was competitively awarded without set-aside restrictions and is scheduled for completion by September 3, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania, utilizing firm fixed-price pricing for this pharmaceutical supply delivery. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This comprehensive IDC serves as the primary vehicle for supplying pharmaceuticals and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's role as a major pharmaceutical distributor and healthcare solutions provider makes it a critical vendor in the federal medical supply chain, supporting diverse therapeutic requirements across the Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/2/25 |